Viral encephalitis: Difference between revisions

Jump to navigation Jump to search
Line 23: Line 23:
==Treatment==
==Treatment==
[[Encephalitis medical therapy|Medical Therapy]] | [[Encephalitis primary prevention|Primary Prevention]] | [[Encephalitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Encephalitis future or investigational therapies|Future or Investigational Therapies]]
[[Encephalitis medical therapy|Medical Therapy]] | [[Encephalitis primary prevention|Primary Prevention]] | [[Encephalitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Encephalitis future or investigational therapies|Future or Investigational Therapies]]
===Antiviral therapy===
* '''Human herpesvirus 6 treatment'''<ref name="pmid25582535">{{cite journal| author=Tong LX, Worswick SD| title=Viral infections in acute graft-versus-host disease: a review of diagnostic and therapeutic approaches. | journal=J Am Acad Dermatol | year= 2015 | volume= 72 | issue= 4 | pages= 696-702 | pmid=25582535 | doi=10.1016/j.jaad.2014.12.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25582535  }} </ref><ref name="pmid15653828">{{cite journal| author=De Bolle L, Naesens L, De Clercq E| title=Update on human herpesvirus 6 biology, clinical features, and therapy. | journal=Clin Microbiol Rev | year= 2005 | volume= 18 | issue= 1 | pages= 217-45 | pmid=15653828 | doi=10.1128/CMR.18.1.217-245.2005 | pmc=PMC544175 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15653828  }} </ref>
:* Preferred regimen: supportive therapy
:* Note: If patient is immunocompromised, there are no antiviral regimens stablished as there are no clinical trials to validate their use on these cases. Consider administering [[Ganciclovir]], [[Acyclovir]], [[Foscarnet]] {{or}} [[Cidofovir]].<ref name="pmid22819486">{{cite journal| author=Wolz MM, Sciallis GF, Pittelkow MR| title=Human herpesviruses 6, 7, and 8 from a dermatologic perspective. | journal=Mayo Clin Proc | year= 2012 | volume= 87 | issue= 10 | pages= 1004-14 | pmid=22819486 | doi=10.1016/j.mayocp.2012.04.010 | pmc=PMC3538396 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22819486  }} </ref><ref name="pmid15653828">{{cite journal| author=De Bolle L, Naesens L, De Clercq E| title=Update on human herpesvirus 6 biology, clinical features, and therapy. | journal=Clin Microbiol Rev | year= 2005 | volume= 18 | issue= 1 | pages= 217-45 | pmid=15653828 | doi=10.1128/CMR.18.1.217-245.2005 | pmc=PMC544175 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15653828  }} </ref>


==Case Studies==
==Case Studies==

Revision as of 16:56, 28 August 2015